The Value of 3D Printing for Product and Clinical Development: 4C Medical’s Perspective
About this webinar
4C Medical Technologies' minimally invasive technology addresses mitral regurgitation and could be an option for patients that are not eligible for surgery. The company’s easy-to-use AltaValve involves the insertion of a flexible implant into the left atrium through a catheter.
As a startup, 4C Medical Technologies faced a long road in putting their device on the market. In our webinar, Dr. Kumar outlines that a great idea alone isn’t enough. Issues like understanding patient anatomy and selecting the sizes for the target population need to be confidently explained to investors and regulatory bodies. Learn how Materialise supported them in the development process.
What you will learn
- The key elements for a successful startup in the medical field
- At which stages of the medical device design live cycle accurate 3D models and 3D printing add value
- How 4C’s collaboration with Materialise supported them throughout the process and helped save time
Vice President of R&D and Operations, 4C Medical Technologies
Saravana Kumar is currently Vice President of R&D and Operations at 4C Medical Technologies, a company developing an innovative solution for the treatment of mitral valve regurgitation. Prior to 4C Medical, Saravana served as Senior Director of R&D and Operations at Conventus Orthopaedics, and led engineering teams at St. Jude Medical for the successful development and commercialization of a transcatheter aortic valve replacement technology. Saravana received his PhD in Mechanical Engineering from the University of Minnesota, his Master’s degree from the University of North Carolina, and his Bachelor’s degree from the University of Delhi in India.